换一批
换一批
作者：
Xin,Yang [1]
;
Honglin,Song [1]
;
Goska,Leslie [2]
;
Christoph,Engel [1]
;
Eric,Hahnen [3]
;
Bernd,Auber [4]
;
Judit,Horváth [5]
;
Karin,Kast [6]
;
Dieter,Niederacher [7]
;
Clare,Turnbull [8]
;
Richard,Houlston [9]
;
Helen,Hanson [10]
;
Chey,Loveday [11]
;
Jill S,Dolinsky [12]
;
Holly,LaDuca [12]
;
Susan J,Ramus [12]
;
Usha,Menon [12]
;
Adam N,Rosenthal [13]
;
Ian,Jacobs [13]
;
Simon A,Gayther [14]
;
Ed,Dicks [15]
;
Heli,Nevanlinna [16]
;
Kristiina,Aittomäki [17]
;
Liisa M,Pelttari [18]
;
Hans,Ehrencrona [18]
;
Åke,Borg [19]
;
Anders,Kvist [20]
;
Barbara,Rivera [21]
;
Thomas V O,Hansen [2]
;
Malene,Djursby [22]
;
Andrew,Lee [23]
;
Joe,Dennis [22]
;
David D,Bowtell [24]
;
Nadia,Traficante [25]
;
Orland,Diez [26]
;
Judith,Balmaña [26]
;
Stephen B,Gruber [27]
;
Georgia,Chenevix-Trench [28]
;
kConFab,Investigators [29]
;
Allan,Jensen [30]
;
Susanne K,Kjær [30]
;
Estrid,Høgdall [1]
;
Laurent,Castéra [1]
;
Judy,Garber [31]
;
Ramunas,Janavicius [32]
;
Ana,Osorio [31]
;
Lisa,Golmard [32]
;
Ana,Vega [33]
;
Fergus J,Couch [34]
;
Mark,Robson [35]
;
Jacek,Gronwald [36]
;
Susan M,Domchek [37]
;
Julie O,Culver [38]
;
Miguel,de la Hoya [39]
;
Douglas F,Easton [40]
;
William D,Foulkes [40]
;
Marc,Tischkowitz [41]
;
Alfons,Meindl [40]
;
Rita K,Schmutzler [42]
;
Paul D P,Pharoah [43]
;
Antonis C,Antoniou [44]
作者单位：
Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.
[1]
Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.
[2]
Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.
[3]
Faculty of Medicine and University Hospital Cologne, Center for Familial Breast and Ovarian Cancer, University of Cologne, Cologne, Germany.
[4]
Faculty of Medicine and University Hospital Cologne, Center for Integrated Oncology, University of Cologne, Cologne, Germany.
[5]
Institute of Human Genetics, Hannover Medical School, Hannover, Germany.
[6]
Institute of Human Genetics, University of Münster, Münster, Germany.
[7]
Department of Gynecology and Obstetrics, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
[8]
National Center for Tumor Diseases (NCT), Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.
[9]
German Cancer Consortium (DKTK), Dresden and German Cancer Research Center (DKFZ), Heidelberg, Germany.
[10]
Department of Gynecology and Obstetrics, Heinrich-Heine University Düsseldorf, University Hospital Düsseldorf, Düsseldorf, Germany.
[11]
Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
[12]
Ambry Genetics, Aliso Viejo, Canada.
[13]
School of Women's and Children's Health, Faculty of Medicine, University of NSW Sydney, Sydney, New South Wales, Australia.
[14]
Garvan Institute of Medical Research, The Kinghorn Cancer Centre, Sydney, New South Wales, Australia.
[15]
Adult Cancer Program, Lowy Cancer Research Centre, University of NSW Sydney, Sydney, New South Wales, Australia.
[16]
MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.
[17]
Women's Cancer, Institute for Women's Health, University College London, London, UK.
[18]
University of New South Wales, Sydney, New South Wales, Australia.
[19]
University of Manchester, Manchester, UK.
[20]
Center for Bioinformatics and Functional Genomics and the Cedars Sinai Genomics Core, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
[21]
Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
[22]
Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
[23]
Department of Clinical Genetics and Pathology, Laboratory Medicine, Office for Medical Services, Region Skåne, Lund, Sweden.
[24]
Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden.
[25]
Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
[26]
Gerald Bronfman Dept Oncology, Jewish General Hospital, McGill University and Lady Davis Institute, Montréal, QC, Canada.
[27]
Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.
[28]
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
[29]
Department of Clinical Genetics Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
[30]
Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.
[31]
Sir Peter MacCallum, Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.
[32]
Oncogenetics Group, Vall dHebron Institute of Oncology, Barcelona, Spain.
[33]
Clinical and Molecular Genetics Area, University Hospital Vall dHebron, Barcelona, Spain.
[34]
Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
[35]
Department of Medical Oncology, University Hospital of Vall d'Hebron, Barcelona, Spain.
[36]
Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
[37]
Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
[38]
Kathleen Cuningham Foundation Consortium for research into Familial Breast cancer.
[39]
Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark.
[40]
Department of Gynaecology, University of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
[41]
Department of Pathology, Molecular Unit, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark.
[42]
Department of Cancer Biology and Genetics, Normandy Centre for Genomic and Personalized Medicine, François Baclesse Center, Inserm U1245, Caen, France.
[43]
Cancer Risk and Prevention Clinic, Dana-Farber Cancer Institute, Boston, MA, USA.
[44]
Department of Molecular and Regenerative Medicine, Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santariskiu Clinics, Vilnius, Lithuania.
[45]
State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania.
[46]
Centro de Investigación en Red de Enfermedades Raras, Madrid, Spain.
[47]
Human Cancer Genetics Programme, Spanish National Cancer Research Centre, Madrid, Spain.
[48]
Institut Curie, Paris Sciences Lettres Research University, Service de Génétique, Paris, France.
[49]
Fundación Pública Galega de Medicina Xenómica, Santiago de Compostela, Spain.
[50]
Instituto de Investigación Sanitaria de Santiago de Compostela, Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain.
[51]
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
[52]
Department of Medicine, Memorial Sloan Kettering Cancer Center, Clinical Genetics Service, New York, NY, USA.
[53]
Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
[54]
Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
[55]
Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
[56]
Molecular Oncology Laboratory CIBERONC, Hospital Clinico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, Spain.
[57]
Department of Gynecology and Obstetrics, University of Munich, Campus Großhadern, Munich, Germany.
[58]
Faculty of Medicine and University Hospital Cologne, Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany.
[59]
主题词
青少年(Adolescent);成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);乳腺肿瘤(Breast Neoplasms);DNA结合蛋白质类(DNA-Binding Proteins);女(雌)性(Female);遗传关联研究(Genetic Association Studies);疾病遗传易感性(Genetic Predisposition to Disease);基因检测(Genetic Testing);生殖细胞系突变(Germ-Line Mutation);杂合子(Heterozygote);人类(Humans);中年人(Middle Aged);卵巢肿瘤(Ovarian Neoplasms);危险因素(Risk Factors);青年人(Young Adult)
DOI
10.1093/jnci/djaa030
PMID
32107557
发布时间
2024-03-31
- 浏览6
Journal of the National Cancer Institute
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
